BR PHARM CO LTD has a total of 11 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BRIM BIOTECHNOLOGY INC, KAMADA LTD and KHANNA PUSHPA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Peptides | |
#5 | Measuring microorganism processes | |
#6 | Foods | |
#7 | Microorganisms | |
#8 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Kim Seok Soon | 5 |
#2 | Kim Seok-Soon | 4 |
#3 | Park Boon Saeng | 3 |
#4 | Kim Il Gi | 3 |
#5 | Kim Il-Gi | 1 |
#6 | Park Boon-Saeng | 1 |
Publication | Filing date | Title |
---|---|---|
KR20200118516A | Composition for preventing hair loss or promoting hair growth | |
US2019374566A1 | Composition for preventing and treating arthritis, including dna fragment mixture and matrix metalloproteinase production inhibitor | |
KR20190140654A | Composition for preventing and treating arthritis comprising DNA fragments mixture and matrix metalloprotease production inhibitor | |
KR20190065676A | Manufacturing method of high purity DNA fragments mixtures |